Elevation Oncology Inc Defensive Interval Ratio
Elevation Oncology Inc defensive interval ratio. Elevation Oncology Inc (ELEV) has a Defensive Interval Ratio of 1738 days as of March 2025. Defensive assets of $20.16 Million (cash $-, short-term investments $20.16 Million, receivables $-) cover 1738 days of daily cash needs of $11.61K/day. See ELEV working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Elevation Oncology Inc (2021–2024)
Defensive interval ratio of Elevation Oncology Inc from 2021 to 2024. This chart shows how Elevation Oncology Inc's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of March 2025, the ratio stands at 1738 days, meaning defensive assets of $20.16 Million can fund 1738 days of operations without new revenue. Check Elevation Oncology Inc (ELEV) asset resilience to evaluate the company's liquid asset resilience ratio.
Elevation Oncology Inc Defensive Interval Ratio by Year (2021–2024)
Elevation Oncology Inc defensive interval ratio by year from 2021 to 2024. The table below presents the year-by-year Defensive Interval Ratio for Elevation Oncology Inc from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Elevation Oncology Inc (ELEV) total assets.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 3572 days | $43.72 Million | $12.24K/day | $- | $43.72 Million | ▲ +591 days |
| 2023 | 2981 days | $33.85 Million | $11.36K/day | $- | $33.85 Million | ▲ +1949 days |
| 2022 | 1032 days | $44.36 Million | $42.99K/day | $- | $44.36 Million | ▲ +1032 days |
| 2021 | 0 days | $0.00 | $24.08K/day | $- | $0.00 | — |